DOT1L Inhibition Attenuates Graft-Versus-Host Disease by Allogeneic T Cells in Adoptive Immunotherapy Models.

Kagoya, Y., Nakatsugawa, M., Saso, K., Guo, T., Anczurowski, M., Wang, C. H., … Hirano, N. (2018). DOT1L Inhibition Attenuates Graft-Versus-Host Disease by Allogeneic T Cells in Adoptive Immunotherapy Models. Nature Communications, 9(1), 1915.

Date

Tue, 15/05/2018 - 12:00

PubMed ID

29765028

Author(s)

Kagoya Y, Nakatsugawa M, Saso K, Guo T, Anczurowski M, Wang CH, Butler MO, Arrowsmith CH, Hirano N

Year